Search Results 21-30 of 519 for ✈010인증 대량소량인증 ㅌㄹ@KORID010 010 성인인증 가입인증✈

  1. Once-daily Oral VT-464 in Patients With Castration-Resistant Prostate Cancer Progressing on Enzalutamide or Abiraterone. - Mayo Clinic

    The goal of this clinical study is to determine the safety and efficacy of VT-464, a lyase-selective inhibitor of CYP17 and an androgen receptor antagonist, in ...

  2. https://www.mayoclinic.org/patient_consumer_faq.xml

  3. A Study of BHV-3241 in Subjects with Multiple System Atrophy - Mayo Clinic

    Participant eligibility includes age, gender, type and stage of disease, and previous treatments or health concerns. Guidelines differ from study to study, and ...

  4. Registration Request - Intensive Tobacco Treatment Program - Mayo Clinic

    Please provide the following information to help your Mayo Clinic care team assess your medical needs. When you have filled out and submitted this form you will ...

  5. sexually transmitted infections Archives - Mayo Clinic News Network

  6. https://www.mayoclinic.org/condition_consolidated_concepts.xml

  7. https://www.mayoclinic.org/chinese_patient_consumer_video.xml

  8. A Study to Evaluate CPI-006 with Standard of Care vs. Placebo with Standard of Care in Mild-to-moderately Symptomatic Hospitalized Covid-19 Patients (Enrolling by Invitation Only) - Mayo Clinic

    The purpose of this study is to compare the time to recovery of CPI-006 plus Standard of Care (SOC) versus placebo plus SOC in hospitalized participants with ...

  9. Treatment of Moderate to Severe Refractory Crohn's Disease - Mayo Clinic

    This research study is testing an investigational research product called TRX103 as a possible treatment for individuals suffering from Crohn's Disease (CD).

  10. Study to Evaluate the Safety and Effectiveness of BMS-986036 in Adults with Nonalcoholic Steatophepatitis (NASH) and Compensated Liver Cirrhosis - Mayo Clinic

    The purpose of this study is to evaluate the safety and effectiveness of BMS-986036 in adults with nonalcoholic steatophepatitis (NASH) and compensated liver ...